Collegium Pharmaceutical, Inc. (COLL)
47.10
+0.07
(+0.15%)
USD |
NASDAQ |
Dec 10, 13:08
Collegium Pharmaceutical Profit Margin (Quarterly): 15.05% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 35.57% |
| Alnylam Pharmaceuticals, Inc. | 20.10% |
| Altimmune, Inc. | -380.3K% |
| Vertex Pharmaceuticals, Inc. | 34.76% |
| Viking Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 24.26% |
| Return on Assets | 3.59% |
| Return on Invested Capital | 4.84% |
| Gross Profit Margin (Quarterly) | 61.70% |
| Operating Margin (Quarterly) | 30.39% |
| Return on Net Operating Assets | 4.48% |